All about the medicine Lenvatinib
28/01/2022 Alternative Treatments
Price: Check with seller
Description
The FDA approved the drug Lenvatinib in 2015 for the treatment of patients suffering from locally recurrent or metastatic, progressive, radioactive iodine-refractory differentiated thyroid cancer, patients with advanced renal cell carcinoma (RCC) following one prior antiangiogenic therapy, and patients with unresectable hepatocellular carcinoma. The active ingredient in the medicine is Lenvatinib mesylate, and the inactive ingredients are calcium carbonate, mannitol, microcrystalline cellulose, hydroxypropyl cellulose, hydroxypropyl cellulose (type H), and talc. This medicine is supplied in 10 mg and 4 mg capsules for oral administration.
Lenvatinib 10 mg price in India, and one can buy this medicine from many generic medicine suppliers. For more enquiries, contact us on 18008891064.
Comments
More Details